Clinical Trials
40 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
INDIGO
Boston Scientific Corporation
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
Purdue University
ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial
University of Aarhus
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
SECURE
Medtronic - MITG
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
ARROW
Hoffmann-La Roche
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Thomas Jefferson University
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Kyowa Kirin Co., Ltd.
ASPIRIN
University Hospital, Antwerp
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Catalysis SL
GastroBot: Artificial Intelligence Applied to Bowel Preparation
Institute of Gastroenterology and Advance Endoscopy
CanStem303C
Sumitomo Pharma America, Inc.
ALpha-T
Hoffmann-La Roche
The Effect of Mobile Application-Based Bowel Preparation Training on the Patient's Education Whom Colonoscopy is Planned
Istanbul University - Cerrahpasa
ALTER-C-002
Zhejiang University
Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers
H. Lee Moffitt Cancer Center and Research Institute
Validation of Aer-O-Scope Colonoscope System Cecal Intubation
GI View Ltd.
mSILSC
Ruijin Hospital
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feasibility of Intraperitoneal Chemotherapy in the Surgical Treatment of Colon Cancer cT4
State Scientific Centre of Coloproctology, Russian Federation
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Low Residue Diet During 3 Days vs 1 Day Prior Colonoscopy
Parc TaulĂ Hospital Universitari
3-day vs. 1-day Low Residue Diet Influence in Colonoscopy Preparation and Patient Tolerability
Portuguese Oncology Institute, Coimbra
A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy
gicare Pharma Inc.
OPTIC
Imperial College London
Colorectal Cancer Screening in a Community Health Setting
University of Pennsylvania
Evaluating Strategies to Present Colon Cancer Screening Information
Washington University School of Medicine
B-ADENOMA
South Tyneside and Sunderland NHS Foundation Trust
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
DIETCOL
Parc de Salut Mar
Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method
gicare Pharma Inc.
Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Swedish Medical Center
Translation of Colorectal Cancer Screening Guidelines to Practice: A System Intervention
VA Office of Research and Development
Random Comparison of LigaSure and Disposable Staples for Laparoscopic Surgery
University Hospitals Cleveland Medical Center
PeerScope B System™ Clinical Protocol
PeerMedical Ltd.
ASAPOL
Maria Sklodowska-Curie National Research Institute of Oncology
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
New Mexico Cancer Research Alliance
Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer
National Health Research Institutes, Taiwan